ReviewTransgenic research2023
Reasons and riddance of Agrobacterium tumefaciens overgrowth in plant transformation.
Review in Transgenic research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Establishment of a High-Efficiency In Vitro Regeneration andBiotech (Basel (Switzerland)) · 2026Article
- Establishment of an efficient and reliable Agrobacterium-mediated genetic transformation system for the elite male-sterile poplar 'Siyang-1'.BMC plant biology · 2026Article
- Endogenous expression of the wound signal peptide ZmREF1 enhances Agrobacterium-mediated transformation of maize inbred B104.Plant cell reports · 2026Article
- Establishment of an efficientFrontiers in plant science · 2026Article
- Agrobacterium-mediated transformation for virus-induced gene silencing (VIGS) in Castilleja tenuiflora: Cte-chlH and Cte-PDS.Plant cell reports · 2025Article
- Knockout of the Agrobacterium ILVC gene generates a valine-isoleucine auxotrophic strain for plant transformation.Transgenic research · 2025Article
- Effective Use of Novel AuxotrophicPlants (Basel, Switzerland) · 2025Article
- Agrobacterium-Mediated Transformation for the Development of Transgenic Crops; Present and Future Prospects.Molecular biotechnology · 2024Review
- A comprehensive review of in planta stable transformation strategies.Plant methods · 2024Review
- EnhancingFrontiers in plant science · 2024Article
- Analysis ofFrontiers in plant science · 2024Review
- Establishment of a Rapid and EffectivePlants (Basel, Switzerland) · 2023Article
- An Efficient Transformation System for Fast Production ofPlants (Basel, Switzerland) · 2023Article
- Research Progress of Nucleic Acid Detection Technology for Genetically Modified Maize.International journal of molecular sciences · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Agrobacterium tumefaciens-mediated plant transformation has become routine work across the world to study gene function and the production of genetically modified plants. However, several issues hamper the transformation process in a profound way, both directly and indirectly. One of the major concerns is the overgrowth of Agrobacterium, which occasionally appears after the co-cultivation phase of the explant. This phenomenon is reported in several species and seems to spoil the whole transformation process. There are multiple approaches being employed to counter this unwanted growth of bacteria in a few plant species. In reality, once the overgrowth appears, it becomes nearly impossible to cure it. Hence, for the prevention of this phenomenon, numerous factors are regulated. These factors are: explant nature, A. tumefaciens strain, T-DNA vector, co-cultivation (time and condition), acetosyringone, washing medium, antibiotics (type, concentration, combination, incubation period), etc. In this article, we discuss these factors based on available reports. It can be of immense help in formulating viable strategies to control A. tumefaciens overgrowth.
Indexed as
Identifiers
36806963What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.